• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能受体 O-糖基化调节心肌细胞中的 N 端切割和信号转导反应。

β-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes.

机构信息

Department of Pharmacology, Columbia University, New York, NY, USA.

Department of Pharmacology, University of California at Davis, Davis, CA, USA.

出版信息

Sci Rep. 2017 Aug 11;7(1):7890. doi: 10.1038/s41598-017-06607-z.

DOI:10.1038/s41598-017-06607-z
PMID:28801655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5554155/
Abstract

β-adrenergic receptors (βARs) mediate catecholamine actions in cardiomyocytes by coupling to both Gs/cAMP-dependent and Gs-independent/growth-regulatory pathways. Structural studies of the βAR define ligand-binding sites in the transmembrane helices and effector docking sites at the intracellular surface of the βAR, but the extracellular N-terminus, which is a target for post-translational modifications, typically is ignored. This study identifies βAR N-terminal O-glycosylation at Ser/Ser as a mechanism that prevents βAR N-terminal cleavage. We used an adenoviral overexpression strategy to show that both full-length/glycosylated βARs and N-terminally truncated glycosylation-defective βARs couple to cAMP and ERK-MAPK signaling pathways in cardiomyocytes. However, a glycosylation defect that results in N-terminal truncation stabilizes βARs in a conformation that is biased toward the cAMP pathway. The identification of O-glycosylation and N-terminal cleavage as novel structural determinants of βAR responsiveness in cardiomyocytes could be exploited for therapeutic advantage.

摘要

β-肾上腺素能受体(βAR)通过与 Gs/cAMP 依赖性和 Gs 非依赖性/生长调节途径偶联,介导儿茶酚胺在心肌细胞中的作用。βAR 的结构研究定义了跨膜螺旋中的配体结合位点和βAR 细胞内表面的效应器对接位点,但通常忽略了作为翻译后修饰靶点的细胞外 N 端。本研究鉴定了βAR N 端丝氨酸/丝氨酸的 O-糖基化,作为一种防止βAR N 端切割的机制。我们使用腺病毒过表达策略表明,全长/糖基化的βAR 和 N 端截短的糖基化缺陷的βAR 在心肌细胞中都与 cAMP 和 ERK-MAPK 信号通路偶联。然而,导致 N 端截断的糖基化缺陷使βAR 稳定在偏向 cAMP 途径的构象中。在心肌细胞中,O-糖基化和 N 端切割作为βAR 反应性的新型结构决定因素的鉴定,可能被用于治疗优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/6eb6893d42f3/41598_2017_6607_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/a1e7d1bd2c7f/41598_2017_6607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/d382417f6798/41598_2017_6607_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/aa2a9f71ef05/41598_2017_6607_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/f244e29b719c/41598_2017_6607_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/7d3d9f232742/41598_2017_6607_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/e8893a18bf3a/41598_2017_6607_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/6eb6893d42f3/41598_2017_6607_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/a1e7d1bd2c7f/41598_2017_6607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/d382417f6798/41598_2017_6607_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/aa2a9f71ef05/41598_2017_6607_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/f244e29b719c/41598_2017_6607_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/7d3d9f232742/41598_2017_6607_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/e8893a18bf3a/41598_2017_6607_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c72/5554155/6eb6893d42f3/41598_2017_6607_Fig7_HTML.jpg

相似文献

1
β-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes.β-肾上腺素能受体 O-糖基化调节心肌细胞中的 N 端切割和信号转导反应。
Sci Rep. 2017 Aug 11;7(1):7890. doi: 10.1038/s41598-017-06607-z.
2
β-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β-adrenergic receptors.ADAM17 通过β-肾上腺素能受体 N 端切割;氧化还原依赖性下调心肌细胞β-肾上腺素能受体的机制。
J Mol Cell Cardiol. 2021 May;154:70-79. doi: 10.1016/j.yjmcc.2021.01.012. Epub 2021 Feb 6.
3
Trypsin cleavage of the β-adrenergic receptor.胰蛋白酶对β-肾上腺素能受体的切割。
Am J Physiol Heart Circ Physiol. 2022 Mar 1;322(3):H486-H491. doi: 10.1152/ajpheart.00005.2022. Epub 2022 Feb 11.
4
Site-specific -Glycosylation by Polypeptide -Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulates β-Adrenergic Receptor N-terminal Cleavage.由多肽 - N - 乙酰半乳糖胺基转移酶2(GalNAc - 转移酶T2)进行的位点特异性糖基化共同调节β - 肾上腺素能受体N端裂解。
J Biol Chem. 2017 Mar 17;292(11):4714-4726. doi: 10.1074/jbc.M116.730614. Epub 2017 Feb 6.
5
Redox and proteolytic regulation of cardiomyocyte β-adrenergic receptors - a novel paradigm for the regulation of catecholamine responsiveness in the heart.氧化还原和蛋白水解调节心肌细胞β肾上腺素能受体 - 一种调节心脏儿茶酚胺反应性的新范例。
Front Immunol. 2023 Dec 4;14:1306467. doi: 10.3389/fimmu.2023.1306467. eCollection 2023.
6
O-GlcNAc transferase affects the signal transduction of β1 adrenoceptor in adult rat cardiomyocytes by increasing the O-GlcNAcylation of β1 adrenoceptor.O-GlcNAc 转移酶通过增加 β1 肾上腺素能受体的 O-GlcNAc 化来影响成年大鼠心肌细胞中 β1 肾上腺素能受体的信号转导。
Biochem Biophys Res Commun. 2020 Jul 12;528(1):71-77. doi: 10.1016/j.bbrc.2020.05.010. Epub 2020 May 26.
7
Monoamine oxidase A and organic cation transporter 3 coordinate intracellular βAR signaling to calibrate cardiac contractile function.单胺氧化酶 A 和有机阳离子转运体 3 协调细胞内βAR 信号转导,以调节心脏收缩功能。
Basic Res Cardiol. 2022 Jul 17;117(1):37. doi: 10.1007/s00395-022-00944-5.
8
S49G and R389G polymorphisms of the β₁-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways.β₁-肾上腺素能受体的 S49G 和 R389G 多态性影响 cAMP-PKA 和 ERK 通路的信号转导。
Physiol Genomics. 2013 Dec 1;45(23):1186-92. doi: 10.1152/physiolgenomics.00087.2013. Epub 2013 Oct 22.
9
Alternative signaling: cardiomyocyte beta1-adrenergic receptors signal through EGFRs.替代性信号传导:心肌细胞β1-肾上腺素能受体通过表皮生长因子受体进行信号传导。
J Clin Invest. 2007 Sep;117(9):2396-8. doi: 10.1172/JCI33135.
10
Altered O-glycosylation of β-adrenergic receptor N-terminal single-nucleotide variants modulates receptor processing and functional activity.β-肾上腺素能受体N端单核苷酸变体的O-糖基化改变调节受体加工和功能活性。
FEBS J. 2025 Mar;292(5):998-1018. doi: 10.1111/febs.17257. Epub 2024 Aug 29.

引用本文的文献

1
Altered β-Adrenergic System, Cardiac Dysfunction, and Lethal Arrhythmia in a Rat Model of Metabolic Syndrome.代谢综合征大鼠模型中的β-肾上腺素能系统改变、心脏功能障碍及致死性心律失常
Int J Mol Sci. 2025 Aug 19;26(16):7989. doi: 10.3390/ijms26167989.
2
Altered O-glycosylation of β-adrenergic receptor N-terminal single-nucleotide variants modulates receptor processing and functional activity.β-肾上腺素能受体N端单核苷酸变体的O-糖基化改变调节受体加工和功能活性。
FEBS J. 2025 Mar;292(5):998-1018. doi: 10.1111/febs.17257. Epub 2024 Aug 29.
3
Adrenoceptor Desensitization: Current Understanding of Mechanisms.

本文引用的文献

1
Glycans and glycoproteins as specific biomarkers for cancer.糖链和糖蛋白作为癌症的特异性生物标志物。
Anal Bioanal Chem. 2017 Jan;409(2):395-410. doi: 10.1007/s00216-016-9880-6. Epub 2016 Sep 3.
2
What Have We Learned from Glycosyltransferase Knockouts in Mice?我们从敲除小鼠糖基转移酶的实验中学到了什么?
J Mol Biol. 2016 Aug 14;428(16):3166-3182. doi: 10.1016/j.jmb.2016.03.025. Epub 2016 Mar 31.
3
A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation.一项关于位点特异性O-糖基化对ADAM介导的胞外域脱落调节作用的系统性研究。
肾上腺素能受体脱敏:对机制的当前理解
Pharmacol Rev. 2024 May 2;76(3):358-387. doi: 10.1124/pharmrev.123.000831.
4
Emerging Roles of UDP-GalNAc Polypeptide N-Acetylgalactosaminyltransferases in Cardiovascular Disease.UDP-N-乙酰半乳糖胺多肽N-乙酰半乳糖胺基转移酶在心血管疾病中的新作用
Aging Dis. 2024 Mar 14;16(1):239-49. doi: 10.14336/AD.2024.0308.
5
Protein glycosylation in cardiovascular health and disease.心血管健康与疾病中的蛋白质糖基化
Nat Rev Cardiol. 2024 Aug;21(8):525-544. doi: 10.1038/s41569-024-00998-z. Epub 2024 Mar 18.
6
Redox and proteolytic regulation of cardiomyocyte β-adrenergic receptors - a novel paradigm for the regulation of catecholamine responsiveness in the heart.氧化还原和蛋白水解调节心肌细胞β肾上腺素能受体 - 一种调节心脏儿茶酚胺反应性的新范例。
Front Immunol. 2023 Dec 4;14:1306467. doi: 10.3389/fimmu.2023.1306467. eCollection 2023.
7
Beta-Adrenergic Receptor Cleavage and Regulation by Elastase.β-肾上腺素能受体的切割与弹性蛋白酶的调节作用
JACC Basic Transl Sci. 2023 May 17;8(8):976-988. doi: 10.1016/j.jacbts.2023.02.002. eCollection 2023 Aug.
8
Dissecting Beta-Adrenergic Receptors: The Sum of Many Parts.剖析β-肾上腺素能受体:众多部分的总和
JACC Basic Transl Sci. 2023 Aug 28;8(8):989-991. doi: 10.1016/j.jacbts.2023.05.005. eCollection 2023 Aug.
9
Reg-1α, a New Substrate of Calpain-2 Depending on Its Glycosylation Status.Reg-1α,钙蛋白酶-2 的新底物,依赖于其糖基化状态。
Int J Mol Sci. 2022 Aug 2;23(15):8591. doi: 10.3390/ijms23158591.
10
Trypsin cleavage of the β-adrenergic receptor.胰蛋白酶对β-肾上腺素能受体的切割。
Am J Physiol Heart Circ Physiol. 2022 Mar 1;322(3):H486-H491. doi: 10.1152/ajpheart.00005.2022. Epub 2022 Feb 11.
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14623-8. doi: 10.1073/pnas.1511175112. Epub 2015 Nov 9.
4
Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy.用于心肌肥厚糖肽和聚糖分析的整合糖蛋白固定方法
Anal Chem. 2015 Oct 6;87(19):9671-8. doi: 10.1021/acs.analchem.5b01663.
5
Functional Divergence in the Role of N-Linked Glycosylation in Smoothened Signaling.N-糖基化在Smo蛋白信号传导中作用的功能分化
PLoS Genet. 2015 Aug 20;11(8):e1005473. doi: 10.1371/journal.pgen.1005473. eCollection 2015 Aug.
6
The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.转唾液酸酶,克氏锥虫的主要毒力因子:三十年研究历程
Glycobiology. 2015 Nov;25(11):1142-9. doi: 10.1093/glycob/cwv057. Epub 2015 Jul 29.
7
Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction.先天性糖基化障碍:糖萼功能障碍简明图表。
Trends Biochem Sci. 2015 Jul;40(7):377-84. doi: 10.1016/j.tibs.2015.03.002. Epub 2015 Mar 31.
8
Glycan imaging in intact rat hearts and glycoproteomic analysis reveal the upregulation of sialylation during cardiac hypertrophy.糖链成像在完整的大鼠心脏和糖蛋白质组学分析中揭示了心脏肥大过程中唾液酸化的上调。
J Am Chem Soc. 2014 Dec 17;136(50):17468-76. doi: 10.1021/ja508484c. Epub 2014 Oct 14.
9
Advances in mass spectrometry driven O-glycoproteomics.质谱驱动的O-糖蛋白质组学进展。
Biochim Biophys Acta. 2015 Jan;1850(1):33-42. doi: 10.1016/j.bbagen.2014.09.026. Epub 2014 Oct 2.
10
Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.通过 SimpleCell 技术对人类 O-糖基化蛋白质组进行精确定位。
EMBO J. 2013 May 15;32(10):1478-88. doi: 10.1038/emboj.2013.79. Epub 2013 Apr 12.